Application of LLM Care and Related Affective Computing Systems on People With Parkinson's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

23 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-01

Study Completion Date

2018-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is an adaptation of the Long Lasting Memories (LLM) (NCT02267499) and the subsequent LLM Care (NCT02313935) projects in patients with Parkinson's Disease (PD). The study aims to examine the viability and any potential benefits of cognitive and physical training, as offered via the ICT-based (non-pharmacological) intervention of LLM Care, on people with PD. It is worth investigating whether this intervention can offer a better quality of life in patients with PD and counterbalance the often associated with the PD disease neurodegeneration. To evaluate any physical, cognitive, behavioral, and neuroplastic changes and measure the influence (affective status of participant) of the training on the pathological population, the study utilizes somatometric and neuropsychological assessments and neuroscientific (electroencephalographic, EEG-related) indices, as well as affective computing systems.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brain Training to Improve Balance in Parkinson's Disease

NCT05986643

Parkinson Disease

RECRUITING NA

Brain Activity During Gait in Parkinson's

NCT04863560

Parkinson Disease

UNKNOWN

Feasibility of Motor-cognitive Home Training for Parkinson's Disease Using eHealth Technology

NCT05027620

Idiopathic Parkinson Disease Telerehabilitation Physical Therapy

COMPLETED NA

Telemedicine Intervention to Improve Cognitive Function

NCT02248649

Parkinson's Disease

COMPLETED NA

Effects of Exercise With Visual Feedback in Parkinson's Disease

NCT07322939

Parkinson Disease Balance Impairment Exercise Training +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Parkinson's Disease (PD) is a highly prevalent chronic neurodegenerative disease of the central nervous system, with both motor and non-motor symptoms, having a high impact on the quality of life of the patients. There is still no cure available for individuals with PD but only pharmaceutical treatments that manage the symptoms, thus non-pharmaceutical treatments such as physical and cognitive training are of great importance. This study aims to evaluate the benefits of the LLM Care (NCT02313935) Integrated Healthcare System (https://www.llmcare.gr/en/home/), which is a successful example of commercializing the LLM (NCT02267499) research program (http://www.longlastingmemories.eu/), in patients with PD. The LLM Care (non-pharmaceutical) intervention is an integrated training system that targets nondemented and demented aging population and adopts an approach of cognitive and physical training to improve the quality of life and prolong the functionality of the elders. The physical training (PT) component of the LLM, WebFitForAll, was developed by the research team of the Medical Physics Laboratory, Department of Medicine, Aristotle University of Thessaloniki. WebFitForAll is an effective physical platform that strengthens the body and enhances aerobic capacity, flexibility, and balance. The cognitive training (CT) component of the LLM is a Greek adaptation of the BrainHQ online interactive environment, and comprises six categories with 29 brain exercises with hundred levels of difficulty. The exercises focus on attention, memory, brain speed, people skills, navigation, and intelligence. The target population is PD patients which were classified according to their cognitive state as PD-cognitively normal (PD-CN) and PD-mild cognitive impairment (PD-MCI). Both PD-CN and PD-MCI followed similar training schemes of the intervention, two times per week for one hour for a total of 10 weeks (aiming at 20 sessions/individual). Specifically, the patients were categorized as follows: (i) LLM training group, where participants attended a training protocol consisting of pseudo-randomized physical and cognitive exercises (30 minutes of cognitive and 30 minutes of physical training), (ii) physical training group, whereas participants underwent only physical training (one hour of physical training), and (iii) cognitive training group, in which participants performed cognitive tasks (one hour of cognitive training). The main goal of this study is to quantify the effects of implementing the LLM Care intervention on patients with PD, determine any benefits in physical status, cognition, behavior, and brain function, and eventually assess if adopting a cognitively and physically stimulating lifestyle can offer a better quality of life in this pathological group. All of the patients were evaluated at baseline (pre) and exit (post) via EEG measures and a battery of routinely used clinical and neuropsychological tests. Additionally, the training platform utilizes affective computing systems to evaluate the affective status of all participants throughout the training and to establish a pleasant learning environment for all participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Participants are assigned to a group following different interventions

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LLM Care

LLM Care training Participants use the webFitForAll exergaming computer platform as the physical training component (PT); Participants use the language adapted version of the BrainHQ Program as the cognitive training component (CT)

Group Type EXPERIMENTAL

webFitForAll

Intervention Type OTHER

PT training participants use the webFitForAll exergaming computer platform as the physical training component (PT)

BrainHQ

Intervention Type OTHER

CT training participants use the language adapted version of the BrainHQ program as the cognitive training component (CT)

Physical Training (PT)

Physical training only. Participants use the webFitForAll exergaming computer platform as the physical training component (PT).

Group Type EXPERIMENTAL

webFitForAll

Intervention Type OTHER

PT training participants use the webFitForAll exergaming computer platform as the physical training component (PT)

Cognitive Training (CT)

Cognitive training only. Participants use the language adapted Version of the BrainHQ Program as the cognitive training component (CT).

Group Type EXPERIMENTAL

BrainHQ

Intervention Type OTHER

CT training participants use the language adapted version of the BrainHQ program as the cognitive training component (CT)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

webFitForAll

PT training participants use the webFitForAll exergaming computer platform as the physical training component (PT)

Intervention Type OTHER

BrainHQ

CT training participants use the language adapted version of the BrainHQ program as the cognitive training component (CT)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PT CT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 50 years and older
2. Native level speakers of the Greek language
3. Able to commit for the required intervention time
4. No significant mobility problems (upper or lower limbs)
5. Normal or corrected to normal visual and auditory acuity
6. In case of any chronic diseases, such as hypertension, diabetes, etc., there should be advice from the competent doctor
7. No serious cardiovascular problems
8. Mild physical activity supervised by a physician
9. Stable medication so as not to affect the patient's functionality from Parkinson's motor symptoms (e.g., stiffness, dyskinesia, restlessness, gait disorder and instability, etc.)

Exclusion Criteria

1. History of serious neurological diseases or psychiatric illness
2. Recent (within 6 months) history of stroke, transient ischemic stroke episode, traumatic brain injury, ALS, multiple sclerosis
3. Substance abuse
4. Use of acetylcholinesterase inhibitor is not excluded, as long as its use has started 4 months before joining the study, and is stable during its course study remains constant
5. Significant communication disorders
6. Simultaneous enrolment in other studies
7. Patients suspected of not being able or willing to cooperate or comply with study protocol requirements
8. Statin users may be excluded unless during the study the use is constant
9. Patients diagnosed in stages 4 and 5 of the disease, or have undergone surgical treatment

Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No